Compare Abeona Therapeutics Inc (ABEO) vs Western Digital Corp (WDC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Abeona Therapeutics Inc vs Western Digital Corp — how do they compare? Abeona Therapeutics Inc trades at $7.42 (market cap $421.19M), while Western Digital Corp trades at $461.37 (market cap $150.95B). The key difference: Western Digital Corp is far larger — about 358.4× Abeona Therapeutics Inc's market cap, and Western Digital Corp pays a 0.14% dividend while Abeona Therapeutics Inc pays none. Which is the better fit depends on your goals.
| ABEO | WDC | |
|---|---|---|
Market Cap | $421.19M | $150.95B |
Sector | Health | Technology |
52-Week High | $7.45 | $746.23 |
52-Week Low | $4.17 | $74.66 |
Enterprise Value | $276.10M | $150.42B |
Dividend Yield | — | 0.14% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ABEO trades at $7.365, down 1.14% today, amid a bullish technical outlook with moving averages signaling strength. The company reported a net income of $71.18 million in 2025, with a net margin of 454.86%, though revenue remains modest at $5.82 million. Recent news includes CMS granting NTAP status for ZEVASKYN and expanding its treatment center network, indicating commercial progress.
The outlook is supported by strong analyst consensus (66.7% buy ratings) and robust profitability metrics, but risks include high SG&A expenses relative to revenue and a shareholder investigation. Upside hinges on revenue scaling to justify current valuations, with the Q2 2026 earnings call on August 13, 2026, as a key near-term catalyst.
Western Digital (WDC) trades at $454.34, up 3.7% in the last 24 hours, with strong earnings beats in recent quarters and a bullish analyst consensus of 72% buy ratings. The stock faces bearish technical signals but benefits from robust AI-driven storage demand, evidenced by 44% revenue growth in Q4 2026 and a net income margin of 72.95% in 2025. Recent news highlights its positioning as a key player in AI infrastructure, though valuation concerns persist.
The outlook for WDC is positive due to sustained AI storage demand and margin expansion, but risks include high valuation multiples and cyclical industry pressures. With a consensus price target of $665.15, upside potential exists, yet investors should monitor competitive threats and earnings sustainability.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Abeona Therapeutics Inc
Abeona Therapeutics develops gene and cell therapies for rare diseases. Its lead product, ZEVASKYN, is an FDA-approved therapy for recessive dystrophic epidermolysis bullosa (RDEB), a severe and life-threatening genetic skin disorder.
Read more on ABEO →About Western Digital Corp
Western Digital is a vertically integrated supplier of data storage solutions, spanning both hard disk drives and solid-state drives. In the HDD market it forms a practical duopoly with Seagate, and it is the largest global producer of NAND flash chips for SSDs in a joint venture with competitor Kioxia.
Read more on WDC →
